Angiotensin II Induces Delayed Mitogenesis and Cellular Proliferation in Rat Aortic Smooth Muscle Cells. Correlation with the Expression of Specific Endogenous Growth Factors and Reversal by Suramin

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1994 Feb 1

PMID 7509348

Citations 20

Authors

H Weber

D S Taylor

C J Molloy

Affiliations

Soon will be listed here.

Abstract

By means of a rat aortic smooth muscle (RASM) cell culture model, the effects of angiotensin II (AII) on early proto-oncogene gene expression, DNA synthesis, and cell proliferation were measured and compared to known mitogens. In 24-h [3H]-thymidine incorporation assays, AII was found to be a weak mitogen when compared to potent mitogens such as fetal bovine serum and platelet-derived growth factor (PDGF). In contrast, when assays were carried out for 48 h, AII induced a significant dose-dependent stimulation of DNA synthesis, which more than doubled at 3 nM AII, and was maximal (five- to eightfold above control) at 100 nM AII. Treatment of cells with the AII type 1 receptor antagonist losartan inhibited the mitogenic effects of AII. AII also stimulated smooth muscle cell proliferation, as indicated by an absolute increase in cell number after AII stimulation of RASM cells for 5 d. AII stimulation of RASM cell growth correlated with the increased expression of specific endogenous growth factors, including transforming growth factor beta 1 (TGF-beta 1) and PDGF A-chain. However, addition of either PDGF- or TGF-beta 1-neutralizing antibodies failed to significantly reduce the delayed mitogenic effects induced by AII. In contrast, we found that AII-stimulated mitogenesis could be inhibited in a dose-dependent manner by the growth factor inhibitor drug suramin. Taken together, our results indicate that enhanced endogenous growth factor expression may represent the direct mechanism by which AII promotes smooth muscle cell growth in some vascular hyperproliferative diseases.

Citing Articles

Unravelling the Lesser Known Facets of Angiotensin II Type 1 Receptor.

Chaudhary M, Chaudhary S Curr Hypertens Rep. 2017; 19(1):1.

PMID: 28083801 DOI: 10.1007/s11906-017-0699-0.

Angiotensin II-induced arterial thickening, fibrosis and stiffening involves elevated arginase function.

Bhatta A, Yao L, Toque H, Shatanawi A, Xu Z, Caldwell R PLoS One. 2015; 10(3):e0121727.

PMID: 25807386 PMC: 4373900. DOI: 10.1371/journal.pone.0121727.

New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.

Zhuo J, Li X Peptides. 2011; 32(7):1551-65.

PMID: 21699940 PMC: 3137727. DOI: 10.1016/j.peptides.2011.05.012.

Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation.

Buharalioglu C, Song C, Yaghini F, Ghafoor H, Motiwala M, Adris T Am J Physiol Heart Circ Physiol. 2011; 301(3):H1043-55.

PMID: 21642504 PMC: 3191073. DOI: 10.1152/ajpheart.01018.2010.

Neferine inhibits angiotensin II-stimulated proliferation in vascular smooth muscle cells through heme oxygenase-1.

Li X, Tong G, Zhang Y, Liu S, Jin Q, Chen H Acta Pharmacol Sin. 2010; 31(6):679-86.

PMID: 20523338 PMC: 4002979. DOI: 10.1038/aps.2010.57.

References

ROBERTSON Jr A . Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol. 1981; 35(2):265-76. DOI: 10.1016/0014-4800(81)90066-6. View

Molloy C, Taylor D, Weber H . Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem. 1993; 268(10):7338-45. View

Hosang M . Suramin binds to platelet-derived growth factor and inhibits its biological activity. J Cell Biochem. 1985; 29(3):265-73. DOI: 10.1002/jcb.240290310. View

Crozat A, Penhoat A, Saez J . Processing of angiotensin II (A-II) and (Sar1,Ala8)A-II by cultured bovine adrenocortical cells. Endocrinology. 1986; 118(6):2312-8. DOI: 10.1210/endo-118-6-2312. View

Griendling K, Rittenhouse S, Brock T, Ekstein L, Gimbrone Jr M, Alexander R . Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem. 1986; 261(13):5901-6. View

Betsholtz C, Johnsson A, Heldin C, Westermark B, Lind P, Urdea M . cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature. 1986; 320(6064):695-9. DOI: 10.1038/320695a0. View

Ross R, Raines E, Bowen-Pope D . The biology of platelet-derived growth factor. Cell. 1986; 46(2):155-69. DOI: 10.1016/0092-8674(86)90733-6. View

Betsholtz C, Johnsson A, Heldin C, Westermark B . Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin. Proc Natl Acad Sci U S A. 1986; 83(17):6440-4. PMC: 386519. DOI: 10.1073/pnas.83.17.6440. View

Walker L, Bowen-Pope D, Ross R, Reidy M . Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci U S A. 1986; 83(19):7311-5. PMC: 386706. DOI: 10.1073/pnas.83.19.7311. View

10.

Owens G . Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension. 1987; 9(2):178-87. DOI: 10.1161/01.hyp.9.2.178. View

11.

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

12.

Coughlin S, Barr P, Cousens L, Fretto L, Williams L . Acidic and basic fibroblast growth factors stimulate tyrosine kinase activity in vivo. J Biol Chem. 1988; 263(2):988-93. View

13.

Keating M, Williams L . Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells. Science. 1988; 239(4842):914-6. DOI: 10.1126/science.2829358. View

14.

Geisterfer A, Peach M, Owens G . Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988; 62(4):749-56. DOI: 10.1161/01.res.62.4.749. View

15.

Huang S, Huang J . Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells and reversal by suramin. Implications for the mechanism of autocrine transformation. J Biol Chem. 1988; 263(25):12608-18. View

16.

Owens G, Geisterfer A, Yang Y, Komoriya A . Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol. 1988; 107(2):771-80. PMC: 2115195. DOI: 10.1083/jcb.107.2.771. View

17.

Taubman M, Berk B, Izumo S, Tsuda T, Alexander R, Nadal-Ginard B . Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. J Biol Chem. 1989; 264(1):526-30. View

18.

Olashaw N, Pledger W . Cellular mechanisms regulating proliferation. Adv Second Messenger Phosphoprotein Res. 1988; 22:139-73. View

19.

Dasch J, Pace D, Waegell W, Inenaga D, Ellingsworth L . Monoclonal antibodies recognizing transforming growth factor-beta. Bioactivity neutralization and transforming growth factor beta 2 affinity purification. J Immunol. 1989; 142(5):1536-41. View

20.

Williams L . Signal transduction by the platelet-derived growth factor receptor. Science. 1989; 243(4898):1564-70. DOI: 10.1126/science.2538922. View